Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC CPI-637 | 1884712-47-3 | 99.9% | 386.45 | C22H22N6O | 100 MG
Supplier: Medchemexpress LLC HY100482100MG
CPI-637 is a selective, cell-active CBP/EP300 bromodomain inhibitor that exhibits low-nanomolar biochemical potency and confirmed cellular activity. It inhibits CBP and EP300 with IC50 values in the tens of nanomolar range, shows substantially weaker activity against BRD4 BD-1, and has reported cellular EC50 and antiproliferative effects in multiple cancer cell lines. It is supplied as a high-purity research compound for epigenetics and oncology studies.
- Selective CBP/EP300 bromodomain inhibition.
- Low-nanomolar biochemical potency.
- Demonstrated cellular activity and EC50 measurements.
- Antiproliferative effects reported in multiple cancer cell lines.
- High chemical purity suitable for research.
- Supplied as a 100 mg research pack.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?